Administration of Recombinant Heat Shock Protein 70 Delays Peripheral Muscle Denervation in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis

A prominent clinical feature of ALS is muscle weakness due to dysfunction, denervation and degeneration of motoneurons (MNs). While MN degeneration is a late stage event in the ALS mouse model, muscle denervation occurs significantly earlier in the disease. Strategies to prevent this early denervati...

Full description

Saved in:
Bibliographic Details
Main Authors: David J. Gifondorwa, Ramon Jimenz-Moreno, Crystal D. Hayes, Hesam Rouhani, Mac B. Robinson, Jane L. Strupe, James Caress, Carol Milligan
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Neurology Research International
Online Access:http://dx.doi.org/10.1155/2012/170426
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550680806555648
author David J. Gifondorwa
Ramon Jimenz-Moreno
Crystal D. Hayes
Hesam Rouhani
Mac B. Robinson
Jane L. Strupe
James Caress
Carol Milligan
author_facet David J. Gifondorwa
Ramon Jimenz-Moreno
Crystal D. Hayes
Hesam Rouhani
Mac B. Robinson
Jane L. Strupe
James Caress
Carol Milligan
author_sort David J. Gifondorwa
collection DOAJ
description A prominent clinical feature of ALS is muscle weakness due to dysfunction, denervation and degeneration of motoneurons (MNs). While MN degeneration is a late stage event in the ALS mouse model, muscle denervation occurs significantly earlier in the disease. Strategies to prevent this early denervation may improve quality of life by maintaining muscle control and slowing disease progression. The precise cause of MN dysfunction and denervation is not known, but several mechanisms have been proposed that involve potentially toxic intra- and extracellular changes. Many cells confront these changes by mounting a stress response that includes increased expression of heat shock protein 70 (Hsp70). MNs do not upregulate Hsp70, and this may result in a potentially increased vulnerability. We previously reported that recombinant human hsp70 (rhHsp70) injections delayed symptom onset and increased lifespan in SOD1G93A mice. The exogenous rhHsp70 was localized to the muscle and not to spinal cord or brain suggesting it modulates peripheral pathophysiology. In the current study, we focused on earlier administration of Hsp70 and its effect on initial muscle denervation. Injections of the protein appeared to arrest denervation with preserved large myelinated peripheral axons, and reduced glial activation.
format Article
id doaj-art-2715d4388d624a5bb555273853e62521
institution Kabale University
issn 2090-1852
2090-1860
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Neurology Research International
spelling doaj-art-2715d4388d624a5bb555273853e625212025-02-03T06:06:01ZengWileyNeurology Research International2090-18522090-18602012-01-01201210.1155/2012/170426170426Administration of Recombinant Heat Shock Protein 70 Delays Peripheral Muscle Denervation in the SOD1G93A Mouse Model of Amyotrophic Lateral SclerosisDavid J. Gifondorwa0Ramon Jimenz-Moreno1Crystal D. Hayes2Hesam Rouhani3Mac B. Robinson4Jane L. Strupe5James Caress6Carol Milligan7Department of Neurobiology and Anatomy, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USADepartment of Neurobiology and Anatomy, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USADepartment of Neurobiology and Anatomy, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USADepartment of Neurobiology and Anatomy, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USADepartment of Neurobiology and Anatomy, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USADepartment of Neurobiology and Anatomy, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USAThe ALS Center, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USADepartment of Neurobiology and Anatomy, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USAA prominent clinical feature of ALS is muscle weakness due to dysfunction, denervation and degeneration of motoneurons (MNs). While MN degeneration is a late stage event in the ALS mouse model, muscle denervation occurs significantly earlier in the disease. Strategies to prevent this early denervation may improve quality of life by maintaining muscle control and slowing disease progression. The precise cause of MN dysfunction and denervation is not known, but several mechanisms have been proposed that involve potentially toxic intra- and extracellular changes. Many cells confront these changes by mounting a stress response that includes increased expression of heat shock protein 70 (Hsp70). MNs do not upregulate Hsp70, and this may result in a potentially increased vulnerability. We previously reported that recombinant human hsp70 (rhHsp70) injections delayed symptom onset and increased lifespan in SOD1G93A mice. The exogenous rhHsp70 was localized to the muscle and not to spinal cord or brain suggesting it modulates peripheral pathophysiology. In the current study, we focused on earlier administration of Hsp70 and its effect on initial muscle denervation. Injections of the protein appeared to arrest denervation with preserved large myelinated peripheral axons, and reduced glial activation.http://dx.doi.org/10.1155/2012/170426
spellingShingle David J. Gifondorwa
Ramon Jimenz-Moreno
Crystal D. Hayes
Hesam Rouhani
Mac B. Robinson
Jane L. Strupe
James Caress
Carol Milligan
Administration of Recombinant Heat Shock Protein 70 Delays Peripheral Muscle Denervation in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis
Neurology Research International
title Administration of Recombinant Heat Shock Protein 70 Delays Peripheral Muscle Denervation in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis
title_full Administration of Recombinant Heat Shock Protein 70 Delays Peripheral Muscle Denervation in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis
title_fullStr Administration of Recombinant Heat Shock Protein 70 Delays Peripheral Muscle Denervation in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis
title_full_unstemmed Administration of Recombinant Heat Shock Protein 70 Delays Peripheral Muscle Denervation in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis
title_short Administration of Recombinant Heat Shock Protein 70 Delays Peripheral Muscle Denervation in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis
title_sort administration of recombinant heat shock protein 70 delays peripheral muscle denervation in the sod1g93a mouse model of amyotrophic lateral sclerosis
url http://dx.doi.org/10.1155/2012/170426
work_keys_str_mv AT davidjgifondorwa administrationofrecombinantheatshockprotein70delaysperipheralmuscledenervationinthesod1g93amousemodelofamyotrophiclateralsclerosis
AT ramonjimenzmoreno administrationofrecombinantheatshockprotein70delaysperipheralmuscledenervationinthesod1g93amousemodelofamyotrophiclateralsclerosis
AT crystaldhayes administrationofrecombinantheatshockprotein70delaysperipheralmuscledenervationinthesod1g93amousemodelofamyotrophiclateralsclerosis
AT hesamrouhani administrationofrecombinantheatshockprotein70delaysperipheralmuscledenervationinthesod1g93amousemodelofamyotrophiclateralsclerosis
AT macbrobinson administrationofrecombinantheatshockprotein70delaysperipheralmuscledenervationinthesod1g93amousemodelofamyotrophiclateralsclerosis
AT janelstrupe administrationofrecombinantheatshockprotein70delaysperipheralmuscledenervationinthesod1g93amousemodelofamyotrophiclateralsclerosis
AT jamescaress administrationofrecombinantheatshockprotein70delaysperipheralmuscledenervationinthesod1g93amousemodelofamyotrophiclateralsclerosis
AT carolmilligan administrationofrecombinantheatshockprotein70delaysperipheralmuscledenervationinthesod1g93amousemodelofamyotrophiclateralsclerosis